Purchase Order 75N95025P00405
Award Date 9/22/25
Potential Completion Date 9/21/26
Potential Value $90K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Rosemont, IL 60018, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a Firm Fixed Price purchase order contract worth $265,048.50 to Life Technologies Corporation, a for-profit manufacturer of scientific instruments, reagents, and consumables. The contract is for the delivery of assorted cell culture medium, substrate, and supplements manufactured by Life Technologies. This contract supports the Stem Cell Translation Laboratory within the National...
- This federal contract award, with a total ceiling value of $36,320.00, was made by the National Center for Advancing Translational Sciences (NCATS), which is part of the National Institutes of Health (NIH) under the Department of Health and Human Services (HHS). The contract was awarded to the prime contractor 10X Genomics, Inc. on December 19, 2024 and is for the procurement of 10X Genomics' Chromium X platform and associated single-cell analysis kits and reagents. This is a firm fixed-price...
- The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $509,165.70 firm-fixed-price purchase order to Government Scientific Source Inc. for the delivery of a Mass Cytometry Imaging System. This system will be used by the National Center for Advancing Translational Sciences (NCATS) Stem Cell Translation Laboratory to support their research on induced pluripotent stem cells. The contract is not set aside for any special business...
- The National Center for Advancing Translational Sciences (NCATS), part of the U.S. Department of Health and Human Services, awarded a $83,000.00 firm fixed-price purchase order to Poochon Scientific LLC, a minority-owned small business, for Protein Identification of Mixture Samples by LC/MS/MS and Proteomic Profiling of Antisense Oligonucleotide (ASO) Treated Brain Organoids. This non-competitive, commercial item acquisition is being conducted under simplified acquisition procedures by the...
- The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $63,800.00 firm fixed price purchase order contract to Pelago Bioscience AB, a for-profit limited liability company, to perform "Small Molecule Target Deconvolution via Cellular Thermal Shift Assay (CETSA)." This requirement was originally posted as a Sources Sought notice, seeking information on qualified sources to perform CETSA experiments, including sample...
- The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences (NCATS) awarded a $142,843.00 firm-fixed-price purchase order to Hesperos, Inc., a leading company in organ-on-a-chip technology, to provide scientific testing services. The contract is for the target validation and therapeutic evaluation of drug compound TRND00601748-01 in NGLY1 deficient cell-based models, including motoneurons and neuromuscular junction models. This...
- The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences (NCATS) awarded a $150,000.00 firm fixed-price purchase order to 3Dnamics Inc., a biotechnology company, for services related to the differentiation and characterization of induced pluripotent stem cell (iPSC) lines. This non-competitive commercial item acquisition was conducted under simplified acquisition procedures without a small business set-aside. The services...
- <p>The National Institute on Drug Abuse (NIDA), a civilian agency, awarded a $183,731.46 firm-fixed-price purchase order contract to Oxford Stemtech LTD for scientific support services related to the generation and multiomics profiling of induced pluripotent stem cell-derived neuronal models. The contract does not have a set-aside designation, and the ultimate completion date is September 10, 2025. This contract award is not associated with a larger acquisition vehicle.</p>
- The National Institute on Drug Abuse (NIDA), on behalf of the National Center for Advancing Translational Sciences (NCATS), awarded a $99,000 firm fixed-price purchase order to Life Technologies Corporation, doing business as Thermo Fisher Scientific, to independently provide services to obtain kinases' percent inhibition for 5,000 data points at one concentration and 400 IC50 curves of malaria compounds. This non-competitive acquisition leverages Life Technologies' specialized expertise in...
- The U.S. Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute on Drug Abuse awarded a $250,000.00 firm-fixed-price purchase order to Standard Biotools Inc., doing business as Fluidigm, to provide customized metal-conjugated antibody services with biochemical analysis. The services will support the NIH National Center for Advancing Translational Sciences (NCATS) Stem Cell Translation Laboratory (SCTL) in detecting and quantifying up to 40...